 Scientific Workshop on Tumor Immune Interactions

Engineered Immune Cells in the Management of Lymphoid Malignancies

View Workshop (ASH registration required)

Program

Current Results with CAR T-cells in Lymphoid Malignancies

Jeremy S. Abramson MD

Massachusetts General Hospital

CD22 and BAFF-R-Directed CAR T-Cells

Larry W. Kwak, MD, PhD  

City of Hope Comprehensive Cancer Center

NK CAR-cells and Allogeneic CAR T-cells

Katayoun Rezvani, MD, PhD  

MD Anderson Cancer Center

Engineered Immune Cells in the Management of Lymphoid Malignancies

Stephen M. Ansell, MD, PhD

Mayo Clinic

Engineered Immune Cells in the Management of Lymphoid Malignancies

Ronald Levy, MD  

Stanford University Medical Center